Search Results - "Sakura, Mizuaki"

Laparoscopic Versus Open Nephroureterectomy in Muscle-Invasive Upper Tract Urothelial Carcinoma: Subanalysis of the Multi-Institutional National Database of the Japanese Urological Association by Miyazaki, Jun, Nishiyama, Hiroyuki, Fujimoto, Hiroyuki, Ohyama, Chikara, Koie, Takuya, Hinotsu, Shiro, Kikuchi, Eiji, Sakura, Mizuaki, Inokuchi, Junichi, Hara, Tomohiko

“…Open nephroureterectomy (ONU) is the current standard for muscle-invasive upper tract urothelial carcinoma (UTUC) in the European Association of…”
Get more information

Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy by Ishioka, Junichiro, Saito, Kazutaka, Kijima, Toshiki, Nakanishi, Yasukazu, Yoshida, Soichiro, Yokoyama, Minato, Matsuoka, Yoh, Numao, Noboru, Koga, Fumitaka, Masuda, Hitoshi, Fujii, Yasuhisa, Sakai, Yasuyuki, Arisawa, Chizuru, Okuno, Tetsuo, Nagahama, Katsuhi, Kamata, Shigeyoshi, Sakura, Mizuaki, Yonese, Junji, Morimoto, Shinji, Noro, Akira, Tsujii, Toshihiko, Kitahara, Satoshi, Gotoh, Shuichi, Higashi, Yotsuo, Kihara, Kazunori

“…Objectives To identify risk factors and develop a model for predicting recurrence of upper urinary tract urothelial carcinoma (UTUC) in the bladder in patients…”
Get full text

Impact of smoking on the age at diagnosis of upper tract urothelial carcinoma: Subanalysis of the Japanese Urological Association multi-institutional national database by Miyazaki, Jun, Nishiyama, Hiroyuki, Fujimoto, Hiroyuki, Ohyama, Chikara, Koie, Takuya, Hinotsu, Shiro, Kikuchi, Eiji, Sakura, Mizuaki, Inokuchi, Junichi, Hara, Tomohiko

“…Objectives To examine the influence of smoking history on the diagnosis and other tumor characteristics of upper tract urothelial carcinoma in Japan. Methods A…”
Get full text

Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery by Urakami, Shinji, Yuasa, Takeshi, Yamamoto, Shinya, Sakura, Mizuaki, Tanaka, Hajime, Hayashi, Tatsuro, Uehara, Sho, Inoue, Yasushi, Fujii, Yasuhisa, Masuda, Hitoshi, Fukui, Iwao, Yonese, Junji

“…Background To determine the indications for post-chemotherapy consolidative surgery in patients with clinical lymph node (LN) metastatic (cN+) urothelial…”
Get full text

Renal function after radical nephrectomy: Development and validation of predictive models in Japanese patients by Yokoyama, Minato, Fujii, Yasuhisa, Takeshita, Hideki, Kawamura, Naoko, Nakayama, Takayuki, Iimura, Yasumasa, Sakura, Mizuaki, Ishioka, Junichiro, Saito, Kazutaka, Koga, Fumitaka, Masuda, Hitoshi, Noro, Akira, Arisawa, Chizuru, Kitahara, Satoshi, Kihara, Kazunori

“…Objectives To develop and validate predictive models for postoperative estimated glomerular filtration rate and risk of chronic kidney disease after radical…”
Get full text

Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association by Hara, Tomohiko, Fujimoto, Hiroyuki, Sakura, Mizuaki, Inokuchi, Junichi, Nishiyama, Hiroyuki, Miyazaki, Jun, Ohyama, Chikara, Koie, Takuya, Kikuchi, Eiji, Hinotsu, Shiro

“…Objectives To explore predictive factors of disease recurrence after radical nephroureterectomy in patients with upper urinary tract urothelial cancer. Methods…”
Get full text

Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association by Koie, Takuya, Ohyama, Chikara, Fujimoto, Hiroyuki, Nishiyama, Hiroyuki, Miyazaki, Jun, Hinotsu, Shiro, Kikuchi, Eiji, Sakura, Mizuaki, Inokuchi, Junichi, Hara, Tomohiko, Ohyama, Chikara, Nishiyama, Hiroyuki, Fujisawa, Masato, Uemura, Hirotsugu, Fujimoto, Hiroyuki, Suzuki, Kazuhiro, Eto, Masatoshi, Hara, Isao, Matsubara, Akio, Nonomura, Norio, Nakanishi, Hiroyuki, Koie, Takuya, Kanayama, Hiroomi, Miki, Tsuneharu, Fukumori, Tomoharu, Naito, Seiji

“…We aimed to survey treatment modalities for the patients with Stage II/III urothelial cancer in Japan. We used the multi-institutional national database of the…”
Get full text

Diagnostic performance and safety of a three‐dimensional 14‐core systematic biopsy method by Takeshita, Hideki, Kawakami, Satoru, Numao, Noboru, Sakura, Mizuaki, Tatokoro, Manabu, Yamamoto, Shinya, Kijima, Toshiki, Komai, Yoshinobu, Saito, Kazutaka, Koga, Fumitaka, Fujii, Yasuhisa, Fukui, Iwao, Kihara, Kazunori

“…Objective To investigate the diagnostic performance and safety of a three‐dimensional 14‐core biopsy (3D14PBx) method, which is a combination of the…”
Get full text

Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association by Inokuchi, Junichi, Naito, Seiji, Fujimoto, Hiroyuki, Hara, Tomohiko, Sakura, Mizuaki, Nishiyama, Hiroyuki, Miyazaki, Jun, Kikuchi, Eiji, Hinotsu, Shiro, Koie, Takuya, Ohyama, Chikara

“…Objectives To describe the nature of metastatic upper urinary tract urothelial cancer and determine the prognostic predictors or treatment modality associated…”
Get full text

Perioperative Complications of Radical Cystectomy After Induction Chemoradiotherapy in Bladder-sparing Protocol Against Muscle-invasive Bladder Cancer: A Single Institutional Retrospective Comparative Study with Primary Radical Cystectomy by Iwai, Aki, Koga, Fumitaka, Fujii, Yasuhisa, Masuda, Hitoshi, Saito, Kazutaka, Numao, Noboru, Sakura, Mizuaki, Kawakami, Satoru, Kihara, Kazunori

“…Objective To compare rates of early morbidity after radical cystectomy in patients treated with or without induction chemoradiotherapy (CRT) using a…”
Get full text

Prospective comparative study of single dose versus 3-day administration of antimicrobial prophylaxis in minimum incision endoscopic radical prostatectomy by Sakura, Mizuaki, Kawakami, Satoru, Yoshida, Souichiro, Masuda, Hitoshi, Kobayashi, Tsuyoshi, Kihara, Kazunori

“…Objective:  From the critical stand point against the overuse of antimicrobial agents, appropriate reduction of antimicrobial prophylaxis (AMP) should be…”
Get full text

Performance of prostate-specific antigen mass in estimation of prostate volume in Japanese men with benign prostate hyperplasia by Masuda, Hitoshi, Kawakami, Satoru, Sakura, Mizuaki, Fujii, Yasuhisa, Koga, Fumitaka, Saito, Kazutaka, Numao, Noboru, Yonese, Junji, Fukui, Iwao, Kihara, Kazunori

“…Objectives:  Obese men with benign prostate hyperplasia might have lower serum prostate‐specific antigen because of hemodilution, resulting in underestimation…”
Get full text

Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma by Urakami, Shinji, M.D., Ph.D, Fujii, Yasuhisa, M.D., Ph.D, Yamamoto, Shinya, M.D., Ph.D, Yuasa, Takeshi, M.D., Ph.D, Kitsukawa, Shinichi, M.D., Ph.D, Sakura, Mizuaki, M.D., Ph.D, Yano, Akihiro, M.D., Ph.D, Saito, Kazutaka, M.D., Ph.D, Masuda, Hitoshi, M.D., Ph.D, Yonese, Junji, M.D., Ph.D, Fukui, Iwao, M.D., Ph.D

“…Abstract Objectives This study sought to examine the combination chemotherapy of gemcitabine, etoposide, and cisplatin (GEP) as a first-line treatment for…”
Get full text

Successful management of life‐threatening choriocarcinoma syndrome with rupture of pulmonary metastatic foci causing hemorrhagic shock by Tatokoro, Manabu, Kawakami, Satoru, Sakura, Mizuaki, Kobayashi, Tsuyoshi, Kihara, Kazunori, Akamatsu, Hideki

“…:  We report a case of a man with testicular cancer metastatic to the lung and retroperitoneal lymph node, with significant elevation of serum levels of human…”
Get full text

A novel equation and nomogram including body weight for estimating prostate volumes in men with biopsy-proven benign prostatic hyperplasia by Nakanishi, Yasukazu, Masuda, Hitoshi, Kawakami, Satoru, Sakura, Mizuaki, Fujii, Yasuhisa, Saito, Kazutaka, Koga, Fumitaka, Ito, Masaya, Yonese, Junji, Fukui, Iwao, Kihara, Kazunori

“…Anthropometric measurements, e.g., body weight （BW）, body mass index （BMI）, as well as serum prostate-specific antigen （PSA） and percent-free PSA （%fPSA） have…”
Get full text

Collecting duct carcinoma with acquired cystic disease of the kidney in a long‐term hemodialysis patient by Sakura, Mizuaki, Masuda, Hitoshi, Saito, Kazutaka, Koga, Fumitaka, Kawakami, Satoru, Kihara, Kazunori

“…:  We report a very rare case of collecting or Bellini duct carcinoma (CDC) found in a 60‐year‐old male who had received hemodialysis therapy for 21 years…”
Get full text

Successful therapy of a malignant phyllodes tumor of the prostate after postoperative local failure by Sakura, Mizuaki, Tsukamoto, Tetsurou, Yonese, Junji, Ishikawa, Yuichi, Aoki, Nozomu, Fukui, Iwao

“…A 19-year-old student who had presented with acute urinary retention was referred to our hospital with biopsy diagnosis of proliferating mesenchymal tumor of…”
Get full text

Sequential bilateral minimum incision endoscopic radical nephrectomy in dialysis patients with bilateral renal cell carcinomas by Sakura, Mizuaki, Kawakami, Satoru, Masuda, Hitoshi, Kobayashi, Tsuyoshi, Kageyama, Yukio, Kihara, Kazunori

“…:  Since 1998, we have performed minimum incision endoscopic surgery (MIES) for renal cell carcinoma (RCC). For seven dialysis patients with bilateral RCC, we…”
Get full text

Superior vena cava syndrome caused by supraclavicular lymph node metastasis of renal cell carcinoma by Sakura, Mizuaki, Tsujii, Toshihiko, Yamauchi, Akimasa, Tadokoro, Manabu, Tsukamoto, Tetsuro, Kawakami, Satoru, Yonese, Junji, Fukui, Iwao

“…A 65-year-old woman presented with gross hematuria in February 1997. Left renal tumor was revealed and radical nephrectomy was performed. Pathological…”
Get full text

Efficacy and Safety Profile of Enzalutamide for Japanese Patients with Castration-resistant Prostate Cancer by Yamasaki, Mutsushi, Yuasa, Takeshi, Yamamoto, Shinya, Hayashi, Tatsuro, Ogawa, Masahiro, Sakura, Mizuaki, Masuda, Hitoshi, Fukui, Iwao, Yonese, Junji

“…Enzalutamide is a novel, non-steroidal anti-androgen that was approved for the treatment of patients with castration-resistant prostate cancer (CRPC) in 2014…”
Get full text